Sign in

CIK 0000886744

  • Large accelerated filer
Ticker
GERN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
752287752
Phone
+1 650-473-7700
Business address
919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY, CA, 94404
Former names
GERON CORPORATION
Open-market buys, last 90 days
$62,105
in 2 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$62,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Semerjian Harout +$51K President & CEO 1 filing
  2. Williams Timothy +$11K EVP and Chief Legal Officer 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-05-11 O'Farrell Elizabeth G. Director Grant or award · Stock Option (right to buy) +83,000 83,000
2021-05-11 Bir Dawn Carter Director Grant or award · Stock Option (right to buy) +83,000 83,000
2021-05-11 EASTHAM KARIN Director Grant or award · Stock Option (right to buy) +83,000 83,000
2021-05-11 Spiegel Robert J. Director Grant or award · Stock Option (right to buy) +83,000 83,000
2021-05-11 Molineaux Susan Director Grant or award · Stock Option (right to buy) +83,000 83,000
2021-05-11 LAWLIS V BRYAN Director Grant or award · Stock Option (right to buy) +83,000 83,000
2021-03-31 Spiegel Robert J. Director Grant or award +4,549 119,497
2021-02-02 ROSENFIELD STEPHEN EVP, Chief Legal Off & Sec Grant or award · Employee Stock Option (Right to buy) +300,000 300,000
2021-02-02 Bloom Olivia Kyusuk EVP, Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +300,000 300,000
2021-02-02 BEHRS MELISSA KELLY EVP, Chief Business Officer Grant or award · Employee Stock Option (Right to buy) +300,000 300,000
2021-02-02 SCARLETT JOHN A Chairman, President and CEO Grant or award · Employee Stock Option (Right to buy) +600,000 600,000
2021-02-02 Kapur Anil EVP, Corp Strategy & CCO Grant or award · Employee Stock Option (right to buy) +300,000 300,000
2021-02-02 GRETHLEIN ANDREW J EVP, Chief Operating Officer Grant or award · Employee Stock Option (right to buy) +300,000 300,000
2021-02-02 Rizo Aleksandra EVP, Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +300,000 300,000
2020-12-31 Spiegel Robert J. Director Grant or award +4,520 114,948
2020-09-30 Spiegel Robert J. Director Grant or award +4,130 110,428
2020-08-21 O'Farrell Elizabeth G. Director Purchase +17,441 $1.73 $30K 19,641
2020-06-30 Spiegel Robert J. Director Grant or award +3,297 106,298
2020-06-05 Spiegel Robert J. Director Grant or award · Stock Option (right to buy) +83,000 83,000
2020-06-05 O'Farrell Elizabeth G. Director Grant or award · Stock Option (right to buy) +83,000 83,000

Page 10 of 15 · 291 trades